These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 11479218

  • 1. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S.
    Cancer Res; 2001 Aug 01; 61(15):5796-802. PubMed ID: 11479218
    [Abstract] [Full Text] [Related]

  • 2. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y, Shen K, Yu JR.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307
    [Abstract] [Full Text] [Related]

  • 3. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y, Shen K, He CX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 06; 42(9):617-22. PubMed ID: 17983518
    [Abstract] [Full Text] [Related]

  • 4. Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
    Takeuchi H, Kanzawa T, Kondo Y, Komata T, Hirohata S, Kyo S, Kondo S.
    Int J Oncol; 2004 Jul 06; 25(1):57-63. PubMed ID: 15201989
    [Abstract] [Full Text] [Related]

  • 5. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
    Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S.
    Anticancer Res; 2001 Jul 06; 21(3B):1937-43. PubMed ID: 11497281
    [Abstract] [Full Text] [Related]

  • 6. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.
    Komata T, Kondo Y, Kanzawa T, Ito H, Hirohata S, Koga S, Sumiyoshi H, Takakura M, Inoue M, Barna BP, Germano IM, Kyo S, Kondo S.
    Hum Gene Ther; 2002 Jun 10; 13(9):1015-25. PubMed ID: 12067435
    [Abstract] [Full Text] [Related]

  • 7. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP.
    Gene Ther; 2001 Apr 10; 8(7):568-78. PubMed ID: 11319624
    [Abstract] [Full Text] [Related]

  • 8. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
    Gu J, Kagawa S, Takakura M, Kyo S, Inoue M, Roth JA, Fang B.
    Cancer Res; 2000 Oct 01; 60(19):5359-64. PubMed ID: 11034071
    [Abstract] [Full Text] [Related]

  • 9. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF, Wang YG, Xiao T, Zhang KJ, Li GC, Gu JF, Chu L, Tang WH, Tan WS, Liu XY.
    Cancer Lett; 2009 Dec 28; 286(2):196-205. PubMed ID: 19564073
    [Abstract] [Full Text] [Related]

  • 10. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter.
    Liu J, Zou WG, Lang MF, Luo J, Sun LY, Wang XN, Qian QJ, Liu XY.
    Int J Oncol; 2002 Sep 28; 21(3):661-6. PubMed ID: 12168115
    [Abstract] [Full Text] [Related]

  • 11. A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter.
    Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S.
    Hum Gene Ther; 2000 Jul 01; 11(10):1397-406. PubMed ID: 10910137
    [Abstract] [Full Text] [Related]

  • 12. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
    Gu J, Andreeff M, Roth JA, Fang B.
    Gene Ther; 2002 Jan 01; 9(1):30-7. PubMed ID: 11850720
    [Abstract] [Full Text] [Related]

  • 13. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
    Komata T, Koga S, Hirohata S, Takakura M, Germano IM, Inoue M, Kyo S, Kondo S, Kondo Y.
    Int J Oncol; 2001 Nov 01; 19(5):1015-20. PubMed ID: 11605003
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T, Kondo Y, Koga S, Ko SC, Chung LW, Kondo S.
    Gene Ther; 2000 Dec 01; 7(24):2071-9. PubMed ID: 11223987
    [Abstract] [Full Text] [Related]

  • 15. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH, Song Y, Ma DX, Qu X, Jiang S.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun 01; 39(6):390-5. PubMed ID: 15312323
    [Abstract] [Full Text] [Related]

  • 16. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y, Huang F, Cai H, Zhong S, Liu X, Tan WS.
    J Gene Med; 2008 May 01; 10(5):518-26. PubMed ID: 18338833
    [Abstract] [Full Text] [Related]

  • 17. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
    You YP, Fu Z, Zhao P, Wang CZ, Liu N, Lu AL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec 01; 23(6):605-9. PubMed ID: 17160935
    [Abstract] [Full Text] [Related]

  • 18. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ.
    Gene Ther; 2004 Apr 01; 11(8):658-67. PubMed ID: 14973547
    [Abstract] [Full Text] [Related]

  • 19. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I, Cohen-Barak O, Shachaf C, Ravel Y, Yalon-Hacohen M, Mills GB, Tzukerman M, Skorecki KL.
    Cancer Res; 2001 Jul 15; 61(14):5529-36. PubMed ID: 11454703
    [Abstract] [Full Text] [Related]

  • 20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP.
    Eur J Cancer Prev; 2008 Jun 15; 17(3):209-17. PubMed ID: 18414191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.